PFE SG&A Expense Growth
Pfizer · SG&A Expense Growth
PFE SG&A Expense Growth
Latest reported-9.40%period ending
PFE FY SG&A Growth (YoY) (0.00% → -9.40%)
Latest values, visible window
High-resolution chart · PNG
PFE sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -9.3958% | |
| 1.7968% | |
| 10.3317% | |
| 7.0263% | |
| 7.4912% | |
| -10.0521% | |
| -11.8821% | |
| -2.3756% | |
| -0.1559% | |
| 0.1969% | |
| 5.5245% | |
| -1.656% | |
| -5.5256% | |
| -14.0872% | |
| -9.1882% | |
| 31.366% | |
| 3.7666% | |
| -7.1217% | |
| -0.9058% | |
| 1.2136% | |
| -10.2999% | |
| 10.8975% | |
| 40.5311% | |
| -4.0092% | |
| -1.2498% | |
| 80.1606% | |
| 14.0625% | |
| 12.3487% | |
| -18.0826% | |
| 14.2134% | |
| 20.6574% | |
| -8.3925% | |
| 27.3728% | |
| 7.6261% | |
| 13.0335% | |
| 17.1072% | |
| 12.2206% | |
| 13.0301% | |
| 15.9363% | |
| 12.328% | |
| 0% |